How can you ensure precision, reproducibility and translational relevance when conducting toxicology testing? With more predictive iPSC-based platforms.
Ncardia will be at the American College of Toxicology (ACT) 2025 Annual Meeting, ready to discuss our scalable, high-throughput iPSC solutions and how they meet the complex demands of cardiac, neurological and stem cell safety testing.
Schedule a meeting with us to see how we can help you accelerate timelines, reduce reliance on animal models and generate more predictive safety data from early screening through regulatory submission.